Enyo Pharma SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Enyo Pharma SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10942
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Enyo Pharma SA (Enyo Pharma) is a biopharmaceutical company that develops molecules modulating host functions for the treatment of acute and chronic viral infections. The company provides technology which develops tools combining biological experimentation and computational development to identify key cellular proteins controlling virus replication. It has constructed a database made up of a library of virus derived peptides for the discovery of new antiviral drugs. Enyo Pharma also carries out hits identification and drug candidate’s identification for viral infections, among others. The company has collaborations with the Infectiology Center of Lyonbiopole, Jean Merieux BSL-4 Laboratory and other international academic groups. Enyo Pharma is headquartered in Lyon, France.

Enyo Pharma SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Enyo Pharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
ENYO Pharma Raises USD46.6 Million in Series B Venture Financing 10
Enyo Pharma Raises USD24 Million in Series A Financing 12
Partnerships 13
Enyo Pharma Enters into Agreement with Poxel 13
Licensing Agreements 14
Enyo Pharma Enters into Licensing Agreement with Edelris 14
ENYO Pharma Enters into Licensing Agreement with Poxel 15
Enyo Pharma SA – Key Competitors 16
Enyo Pharma SA – Key Employees 17
Enyo Pharma SA – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
May 11, 2017: ENYO Pharma Strengthens Its Business Team to Support International Growth 19
Clinical Trials 20
Oct 26, 2017: ENYO Pharma Opens a New Subsidiary in Australia as a New Managing Center for Clinical Trials 20
Jun 13, 2017: ENYO Pharma Announces Successful Completion of EYP001 First in Man Phase 1 Study 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Enyo Pharma SA, Pharmaceuticals & Healthcare, Key Facts 2
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Enyo Pharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Enyo Pharma SA, Deals By Therapy Area, 2012 to YTD 2018 8
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ENYO Pharma Raises USD46.6 Million in Series B Venture Financing 10
Enyo Pharma Raises USD24 Million in Series A Financing 12
Enyo Pharma Enters into Agreement with Poxel 13
Enyo Pharma Enters into Licensing Agreement with Edelris 14
ENYO Pharma Enters into Licensing Agreement with Poxel 15
Enyo Pharma SA, Key Competitors 16
Enyo Pharma SA, Key Employees 17

List of Figures
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Enyo Pharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Enyo Pharma SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Edgars Stores Limited:企業の戦略・SWOT・財務情報
    Edgars Stores Limited - Strategy, SWOT and Corporate Finance Report Summary Edgars Stores Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Saudi Electricity Co (5110):企業の財務・戦略的SWOT分析
    Saudi Electricity Co (5110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Tianjin Chase Sun Pharmaceutical Co Ltd (300026):企業の財務・戦略的SWOT分析
    Summary Tianjin Chase Sun Pharmaceutical Co Ltd (Chase Sun) is a medicine and health industry group. The company research, develops, produces, and markets various pharmaceutical products. It offers products such as Chinese herb preparations, Chinese medicinal granules, synthetic drugs, biotech drugs …
  • Beam Suntory Inc.:企業の戦略・SWOT・財務情報
    Beam Suntory Inc. - Strategy, SWOT and Corporate Finance Report Summary Beam Suntory Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • MDNA Life Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test is based on the science of mitochondrial DNA, a tissue-based prostate cancer diagnostics for prostate and other cancers. …
  • Van Oord nv:電力:M&Aディール及び事業提携情報
    Summary Van Oord nv (Van Oord), a subsidiary of MerweOord BV, is a contracting company. It is specialized in dredging, marine engineering and offshore projects including oil, gas, and wind. The company primarily undertakes dredging, offshore oil and gas and offshore wind projects. Its activities inc …
  • Daimler AG (DAI):企業の財務・戦略的SWOT分析
    Daimler AG (DAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Transport for London:企業の戦略的SWOT分析
    Transport for London - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Pakistan International Airlines Corporation
    Pakistan International Airlines Corporation - Strategy, SWOT and Corporate Finance Report Summary Pakistan International Airlines Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Japan Logistics Fund, Inc. :企業の戦略・SWOT・財務情報
    Japan Logistics Fund, Inc. - Strategy, SWOT and Corporate Finance Report Summary Japan Logistics Fund, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Exiqon AS:医療機器:M&Aディール及び事業提携情報
    Summary Exiqon AS (Exiqon), a subsidiary of Qiagen NV, is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company provides product categories such as microRNA research, incRNA research, mRNA research, DNA research, custom oligos and other reag …
  • PizzaExpress Limited:企業の戦略・SWOT・財務情報
    PizzaExpress Limited - Strategy, SWOT and Corporate Finance Report Summary PizzaExpress Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • CS Communication & Systemes SA:企業の戦略・SWOT・財務分析
    CS Communication & Systemes SA - Strategy, SWOT and Corporate Finance Report Summary CS Communication & Systemes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Amphastar Pharmaceuticals Inc (AMPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Amphastar Pharmaceuticals Inc (Amphastar) is a specialty pharmaceutical company that develops, manufactures and markets generic and proprietary injectable, intranasal and inhalation products. It also sells insulin active pharmaceutical ingredient (insulin API) products. The company’s product …
  • Federal Grid Company of Unified Energy System (FEES):企業の財務・戦略的SWOT分析
    Federal Grid Company of Unified Energy System (FEES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Pearl Polymers Ltd.:企業の戦略・SWOT・財務情報
    Pearl Polymers Ltd. - Strategy, SWOT and Corporate Finance Report Summary Pearl Polymers Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • National Aerospace Fasteners Corporation:企業の戦略・SWOT・財務情報
    National Aerospace Fasteners Corporation - Strategy, SWOT and Corporate Finance Report Summary National Aerospace Fasteners Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • EnPro Industries, Inc.:企業のM&A・事業提携・投資動向
    EnPro Industries, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EnPro Industries, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Network Rail Limited:企業の戦略・SWOT・財務情報
    Network Rail Limited - Strategy, SWOT and Corporate Finance Report Summary Network Rail Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • NOW Health Group Inc:企業の戦略・SWOT・財務情報
    NOW Health Group Inc - Strategy, SWOT and Corporate Finance Report Summary NOW Health Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆